Clinical Trial Details

NCT ID: NCT02652091
Date Last Changed: August 10, 2017

Overview

Research Study Summary

A clinical study for patients with Relapsing-Remitting Multiple Sclerosis

Research Study Title

Impact of the BETACONNECT Auto-injector on BETASERON Therapy Adherence and Patient Satisfaction

Purpose

The primary objective of this study is to assess adherence and persistence to BETASERON therapy in patients who are using the BETACONNECT auto-injector device (BETACONNECT device).

The secondary objective of this study is to assess patient-reported satisfaction with the BETACONNECT device.

To Learn more

Recruitment Details

Gender
All
Age
18 and up
Overall Status
Recruiting
Lead Sponsor
Bayer
Duration
18 Months
Facility Type
N/A
Compensation

Eligibility

All ages 18 Years and up

Inclusion Criteria:

  • Male and females greater than or equal to 18 years of age

  • Diagnosis of RRMS according to revised McDonald Criteria (2010) or (CIS)

  • Prescribed BETASERON (note: decision to treat with BETASERON must be made independent of participation in this study)

  • Confirmation of insurance coverage for BETASERON treatment

  • Access to a personal computer to complete online patient satisfaction survey at Week 6.

Exclusion Criteria:

  • Currently enrolled in a clinical trial or other observational study for Multiple Sclerosis treatment

  • Documented substance abuse within the previous 6 months prior to study enrollment

  • Any major laboratory value abnormality that the investigator believes would preclude the patient from participating in the study

  • Any medical disorder, condition or history that in the opinion of the investigator would impair the patient's ability to participate in or complete the study

  • Pregnant or nursing

Site Locations (16)

Country State City Zip Facility and Contact
United States Alabama Cullman 35058 Research Site
United States Florida Boca Raton 33428 Research Site
United States Florida New Port Richey 34653 Research Site
United States Florida Tampa 33609 Research Site
United States Massachusetts Foxborough 02035 Research Site
United States Michigan Deckerville 48427 Research Site
United States New Jersey Stratford 08084 Research Site
United States New Jersey Teaneck 07666 Research Site
United States New York Staten Island 10306 Research Site
United States Pennsylvania Bala-Cynwyd 19004 Research Site
United States Pennsylvania Lititz 17543 Research Site
United States Tennessee Franklin 37064 Research Site
United States Tennessee Memphis 38104 Research Site
United States Tennessee Nashville 37212 Research Site
United States Texas Round Rock 78681 Research Site
United States Virginia Fairfax 22031 Research Site

Contact

Bayer Clinical Trials Contact

E-mail:

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.